Question 1

Have you treated patients with Daxxify specifically, and what results are you seeing compared to Botox in your practice?

Accepted Answer

A good answer is grounded in their own patient outcomes: "I have been using Daxxify for about a year. Most of my patients are getting five to six months, a couple have gone closer to nine. Onset is similar to Botox, maybe slightly faster. I have not seen a different complication profile." This matters because Daxxify is newer and real-world data is still accumulating. You need to know they have actual experience with it, not just manufacturer training. If they give you the SAKURA trial statistics without any personal clinical observations, or if they are offering it without having treated patients with it before, you are potentially their first Daxxify case.

Question 2

Are you dosing it differently from onabotulinumtoxinA, same units, or adjusted?

Accepted Answer

A good answer sounds like: "The SAKURA trials used a 1:1 unit equivalent to Botox for the glabella, and that is what I start with. For off-label areas I am a little more conservative because we have less dosing data there." They should be able to explain the rationale, not just say "same as Botox" without any thought. This matters because the evidence base for off-label Daxxify dosing is thinner than for Botox, which has decades of data across every area of the face. An injector who treats every area identically to their Botox protocol without acknowledging this difference is not thinking critically about what they are doing.

Question 3

Given the longer duration, how do you approach the initial treatment, more conservative to allow adjustment?

Accepted Answer

A good answer sounds like: "Yes, I go a little lighter on a first Daxxify treatment because if we over-correct, you are living with that for six months rather than three. We can always add at the two-week review. I would rather do that than have you unhappy for twice as long." This is exactly the right clinical reasoning. With a 3-month product, an over-correction is uncomfortable for a few weeks. With a 6-month product, the same error lasts significantly longer. An injector who plans to dose aggressively from the start without mentioning this is not accounting for the extended commitment you are making.

Question 4

What is the plan if I want to be reassessed at 2 weeks, is that included?

Accepted Answer

They should confirm it is included and be specific about what a two-week review can address: small areas of remaining movement can be topped up, but they should also be honest that Daxxify cannot be reversed if the outcome is stronger than you wanted. This is an important distinction from HA fillers, which can be dissolved. This matters because it sets accurate expectations: you can fine-tune at two weeks, but you cannot undo a strong result for months. Any clinic that charges extra for a two-week review or discourages it is operating below a reasonable standard of care.

Question 5

Is Daxxify stocked on-site or ordered per patient?

Accepted Answer

A good answer is specific: "We stock it on-site and I use it regularly enough that it is always within the use-by window" or "I order it specifically for your appointment so it comes in fresh." Either is fine. What is not fine is vagueness about storage or handling, or not knowing whether the product they are about to inject has been properly refrigerated and is within date. This matters more for Daxxify than for Botox because it is newer and some smaller clinics may hold a vial longer to use up stock. Proper cold-chain storage is required for the product to work as intended.

Stay informed